We take a look at Oxford’s biotech and life sciences hub to discover what makes this historical city a hotspot for scientific ...

Delve into the Astellas playbook, a strategy relying on "strategic brand" and advancing on "primary focuses" at the same time ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

And the presence of the Barcelona Science Park, which is the first science park in Spain that is home to three research institutes and more than 70 companies, make the city a viable location for ...

Discover how Treg cell therapies rethink precision medicine for autoimmune diseases like type 1 diabetes, MS, and transplant rejection.

As the pharma patent cliff approaches, delve into which important drugs are about to lose exclusivity and how the industry is reacting.

Celebrate International Day of Women and Girls in Science 2026 by discovering some of the most influential women shaping biotech today.

Radioligand therapies gained momentum in 2025 with FDA’s Pluvicto approval. Here’s why 2026 could drive growth and adoption.

No holiday hangover has stopped the biopharma industry from striking partnerships in January. The new year commenced with American pharma giant Amgen’s $840 million buyout of British biotech Dark Blue ...